JP2006528650A5 - - Google Patents

Download PDF

Info

Publication number
JP2006528650A5
JP2006528650A5 JP2006521498A JP2006521498A JP2006528650A5 JP 2006528650 A5 JP2006528650 A5 JP 2006528650A5 JP 2006521498 A JP2006521498 A JP 2006521498A JP 2006521498 A JP2006521498 A JP 2006521498A JP 2006528650 A5 JP2006528650 A5 JP 2006528650A5
Authority
JP
Japan
Prior art keywords
immunogenic composition
composition according
amino acid
peptide
conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006521498A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006528650A (ja
Filing date
Publication date
Priority claimed from FR0309188A external-priority patent/FR2857875A1/fr
Application filed filed Critical
Publication of JP2006528650A publication Critical patent/JP2006528650A/ja
Publication of JP2006528650A5 publication Critical patent/JP2006528650A5/ja
Pending legal-status Critical Current

Links

JP2006521498A 2003-07-25 2004-07-25 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン Pending JP2006528650A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0309188A FR2857875A1 (fr) 2003-07-25 2003-07-25 Vaccin therapeutique cible contre la p-glycoproteine 170 pour inhiber la resistance multidrogues dans le traitement des cancers
PCT/EP2004/008330 WO2005014036A1 (fr) 2003-07-25 2004-07-25 Vaccin therapeutique cible contre la p-glycoproteine 170 pour inhiber la resistance multidrogues dans le traitement des cancers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013018233A Division JP2013121977A (ja) 2003-07-25 2013-02-01 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン

Publications (2)

Publication Number Publication Date
JP2006528650A JP2006528650A (ja) 2006-12-21
JP2006528650A5 true JP2006528650A5 (enExample) 2007-08-30

Family

ID=33561147

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006521498A Pending JP2006528650A (ja) 2003-07-25 2004-07-25 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン
JP2013018233A Withdrawn JP2013121977A (ja) 2003-07-25 2013-02-01 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013018233A Withdrawn JP2013121977A (ja) 2003-07-25 2013-02-01 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン

Country Status (9)

Country Link
US (1) US20060233758A1 (enExample)
EP (2) EP1651257B1 (enExample)
JP (2) JP2006528650A (enExample)
KR (2) KR20130008092A (enExample)
CN (1) CN1856323B (enExample)
AU (1) AU2004262472B2 (enExample)
CA (1) CA2533540C (enExample)
FR (1) FR2857875A1 (enExample)
WO (1) WO2005014036A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8663650B2 (en) 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
US20080026995A1 (en) * 2003-07-25 2008-01-31 Ac Immune Sa Therapeutic vaccine targeted against p-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
US7807171B2 (en) * 2003-07-25 2010-10-05 Ac Immune Sa Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
US8090392B2 (en) * 2005-08-05 2012-01-03 Interdigital Technology Corporation Method and system for reporting a short message capability via an IP multimedia subsystem
EP2468300B1 (en) 2006-09-26 2017-12-20 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
KR101130754B1 (ko) * 2010-06-25 2012-03-28 제일약품주식회사 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물
WO2012020124A1 (en) 2010-08-12 2012-02-16 Ac Immune S.A. Vaccine engineering
EP2632434B1 (en) 2010-10-26 2025-08-20 AC Immune S.A. Liposome-based construct comprising a peptide modified through hydrophobic moieties
SMT201800368T1 (it) 2012-05-16 2018-09-13 Immune Design Corp Vaccini per l'infezione da virus-2 herpes simplex
CA2909221A1 (en) 2013-04-18 2014-10-23 Immune Design Corp. Gla monotherapy for use in cancer treatment
CA3118692A1 (en) 2018-11-06 2020-05-14 Alsatech, Inc. Cell-based gene therapy for neurodegenerative diseases
CN112687354B (zh) * 2019-01-29 2022-07-12 杭州纽安津生物科技有限公司 针对靶向药物PI3K、AKT、mTOR通路的激酶抑制剂的多肽疫苗组合及其设计方法
CN115968376A (zh) * 2020-04-17 2023-04-14 I2O治疗公司 长效胰高血糖素受体选择性肽和使用方法
CN113648429B (zh) * 2021-07-06 2023-11-10 中山大学 靶向肿瘤周围细胞激活免疫的聚合物及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257893B (it) * 1992-06-17 1996-02-16 Ist Superiore Sanita Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
WO1994010198A1 (en) * 1992-11-02 1994-05-11 Yves Claude Nicolau Method of reducing multidrug resistance in cells and tissues
JP3759759B2 (ja) * 1994-03-04 2006-03-29 日本油脂株式会社 リポソームおよび薬物運搬体
JP4385152B2 (ja) * 1997-09-17 2009-12-16 三菱化学株式会社 2価反応性水溶性高分子誘導体及びそれを含有する複合体
JP2002047298A (ja) * 2000-07-10 2002-02-12 Academia Sinica 新規抗がん剤伝達系
US8663650B2 (en) * 2003-02-21 2014-03-04 Ac Immune Sa Methods and compositions comprising supramolecular constructs
CN1849141A (zh) * 2003-05-12 2006-10-18 阿费麦克斯公司 用于聚(乙二醇)修饰的肽的间隔臂部分

Similar Documents

Publication Publication Date Title
ES2551604T3 (es) Vacuna terapéutica
JP2013121977A5 (enExample)
Pöltl-Frank et al. Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine
JP2009510133A5 (enExample)
JP2013121977A (ja) 癌の治療における多剤耐性を抑制するための、p−糖タンパク質170を標的とする治療ワクチン
US8409580B2 (en) Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
CN111499753B (zh) 双功能抗体及其用途
JP5519477B2 (ja) T1免疫応答とt2免疫応答との間で調節するためのワクチン
JP2014503475A5 (enExample)
JP2014518841A (ja) アジュバントを備えたmuc1ベースのグリコリポペプチドワクチン
CN110790829B (zh) pHLIP胞外段作为抗原制备的抗体在制备抗肿瘤药物中的应用
US20240131152A1 (en) Nano-particles that contain synthetic variants of gm3 ganglioside as adjuvants in vaccines
AU2019271143A1 (en) Peptide display to antigen presenting cells using lipid vehicle
Wallis et al. A liposome-based cancer vaccine for a rapid and high-titre anti-ErbB-2 antibody response
US7314956B2 (en) Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cell
JP2001510440A (ja) ムチン接合体ペプチドワクチン
US20050244419A1 (en) Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
US20080175871A1 (en) Eliciting improved immune responses
CN1446094A (zh) 获得可增强特异交叉反应性的抗原结构的方法
US20050255561A1 (en) Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers
Luna González Peptides: from synthesis to biomedical application in two types of cancer
González Peptides: From Synthesis to Biomedical Application in Two Types of Cancer
JP2004509846A (ja) 肝炎c型ウイルスコンジュゲート
KR20230098281A (ko) 조합 면역요법을 위한 모듈형 덴드론 미셀
EA042396B1 (ru) Наночастицы, содержащие синтетические варианты ганглиозида gm3, в качестве адъювантов в вакцинах